Section 1: Personal Particulars

Meiwan CHEN
University of Macau
UMAC-SKL of Quality Research in Chinese Medicine

Research Project provided for Macao Youth Scholars Program:

[1] Research and Development of EBV-mRNA vaccine for nasopharyngeal cancer therapy
1007 药学
0202 应用经济学,0702 物理学,0703 化学,0704 天文学,0705 地理学,0707 海洋科学,0708 地球物理学,0709 地质学,0710 生物学,0713 生态学,0802 机械工程,0803 光学工程,0805 材料科学与工程,0807 动力工程及工程热物理,0808 电气工程,0809 电子科学与技术,0810 信息与通信工程,0811 控制科学与工程,0814 土木工程,0827 核科学与技术,0831 生物医学工程,1001 基础医学,1004 公共卫生与预防医学,1007 药学,1008 中药学
Prof. Chen has published 117 top-tier SCI journals (25 papers with IF>10, 78 papers with IF>5) as the first/corresponding author, including Advanced Materials, ACS Nano, Nano Letters, Biomaterials, and many more. Her publications have been cited >10000 times, with an h-index of 57, with 5 being recognized internationally as “ESI highly cited papers”. She has been in charge 20 projects funded by NSFC as well as the Macau Fund. She also published 6 book chapters and 9 patents. She was awarded the Excellent Young Scientist Fund by National Natural Science Foundation of China in 2019 (the first time opened for HK and Macao applicants) and ‘Qi Huang’ Youth Scholarship by the State Administration of TCM, China in 2020. She was elected as a Fellow of the Royal Society of Chemistry (FRSC) in 2022. She won the Natural Science Award (2nd/2nd/3rd Class) in 2012/2014/2018 and the Science and Technology Progress Award (3rd Class) in 2022, as awarded by the Macao Science and Technology Award. She (co-)supervises more than 30 PhD/MSc graduates: one student received the second prizes in the ‘Challenge Cup’ national inter-varsity competition for extracurricular academic technological projects in 2022; one graduate ranked first under Young Elite Scientist Sponsorship Programme; one student received the 9th China Youth Science and Technology Innovation Award; seven students received the Macao Science and Technology Award-Scientific and Technological R&D Awards for Postgraduates; and more than thirty conference awards.

Section 2: Research Interests and Grants

• Molecular Pharmaceutics • Biomaterial and Nanomedicine • Targeted Drug Delivery System
Research and Development of EBV-mRNA vaccine for nasopharyngeal cancer therapy靶向EB病毒的鼻咽癌mRNA核酸疫苗關鍵技術及產品研發 (FDCT 0096/2020/AMJ,2021/10-2024/09)